Skip to content

A study comparing the differences in using or not using the pain medication remifentanil during general anesthesia with propofol and an I-gel airway device in patients aged 65 years and older

Effect of remifentanil for I-gel insertion with target controlled infusion (TCI) propofol anesthesia in elderly patients aged 65 or older

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0011400
Enrollment
60
Registered
2026-01-02
Start date
2023-05-24
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : General anesthesia was induced using a target-controlled infusion (TCI) system. In both the experimental and control groups, propofol was administered intravenously as the hypnotic agent. In th

Sponsors

Ewha Womans University Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The inclusion criteria for this study included patients aged = 65 with classified under American Society of Anesthesiologists Physical Status (ASA-PS) categories I–III, scheduled for elective surgery lasting < 2 hours under general anesthesia with I-gel insertion.

Exclusion criteria

Exclusion criteria: The exclusion criteria included patients for whom I-gel insertion was anticipated to be difficult, such as those with a Body Mass Index (BMI) of = 35, patients with loose teeth, and those undergoing surgeries where position changes were expected during the procedure, allergies to the study drugs and those with cognitive disorders.

Design outcomes

Primary

MeasureTime frame
Propofol effect-site concentration (Ce);Propofol dose (mg/kg);Time to loss of consciousness and time to I-gel insertion

Secondary

MeasureTime frame
Blood pressure;Heart rate;Bispectral Index (BIS)

Countries

Korea, Republic of

Contacts

Public ContactMin Jeong KANG

Ewha Womans University Medical Center

minjungk128@gmail.com+82-2-2650-5285

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026